Eli Lilly benefits from rising cash flow and a strong pipeline, yet elevated pricing versus peers limits near-term gains. See ...

Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and ...

Eli Lilly's foray into telehealth shows the emerging importance virtual care platforms are playing in the rising popularity ...

OrderlyMeds believes that each person is unique and deserves an individualized medical regimen. Compliantly compounded medications is a critical tool to meet those goals. Eli Lilly's Cease-and ...

Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...

An experimental drug could be game-changing for millions of Americans with a higher genetic risk of cardiovascular disease.

Primary care company knownwell said on Wednesday it will provide health and weight-management services on Eli Lilly's ...